Showing results (431-440 of 464) with videos related to
Sort By:
Pageof 47
Oncotarget|February 11, 2017
PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic featuresEmmanuel K Teye, Abigail Sido, Ping Xin, et al.Cell Death and Differentiation|October 11, 2008
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009G Kroemer, L Galluzzi, P Vandenabeele, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancerW P Bennett, W S el-Deiry, W L Rush, et al.The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.NPJ Precision Oncology|October 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patientsAlberto Puccini, Andreas Seeber, Joanne Xiu, et al.The Journal of Clinical Investigation|July 15, 2024
Targeting apoptotic pathways for cancer therapyXiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, et al.Cell Cycle (Georgetown, Tex.)|November 22, 2017
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignanciesVarun V Prabhu, Mala K Talekar, Amriti R Lulla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.Cancer Research|June 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome ChemoresistanceTulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca, et al.Pageof 47